Cargando…
Recent Developments in Mycobacteria-Based Live Attenuated Vaccine Candidates for Tuberculosis
Vaccination is an excellent approach to stimulating the host immune response and reducing human morbidity and mortality against microbial infections, such as tuberculosis (TB). Bacillus Calmette–Guerin (BCG) is the most widely administered vaccine in the world and the only vaccine approved by the Wo...
Autores principales: | Flores-Valdez, Mario Alberto, Kupz, Andreas, Subbian, Selvakumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687462/ https://www.ncbi.nlm.nih.gov/pubmed/36359269 http://dx.doi.org/10.3390/biomedicines10112749 |
Ejemplares similares
-
Repurposing mucosal delivery devices for live attenuated tuberculosis vaccines
por: Puri, Munish, et al.
Publicado: (2023) -
Development of Mycobacterium tuberculosis attenuated strains as live vaccine candidates for tuberculosis
por: Villela, Anne, et al.
Publicado: (2014) -
Vaccination with an Attenuated Ferritin Mutant Protects Mice against Virulent Mycobacterium tuberculosis
por: Subbian, Selvakumar, et al.
Publicado: (2015) -
BCG Vaccination Prevents Reactivation of Latent Lymphatic Murine Tuberculosis Independently of CD4(+) T Cells
por: Sathkumara, Harindra D., et al.
Publicado: (2019) -
An Overview of SARS-CoV-2 Etiopathogenesis and Recent Developments in COVID-19 Vaccines
por: Mathew, Dona Susan, et al.
Publicado: (2023)